Addus HomeCare (ADUS) has drawn investor attention after recent trading left the stock around $93.26, with performance mixed over the past year and fundamentals that highlight its position in US home-based care services.

The recent move to around $93.26 comes after a modest 7 day share price return of 0.92%. However, the 90 day share price return is down 19.24%, and the 1 year total shareholder return is down 16.38%. This points to fading momentum despite a slightly positive 3 year total shareholder return of 4.98%.

If this kind of pullback has you reviewing ideas beyond healthcare services, it can be a good time to broaden your watchlist with our screener of 20 top founder-led companies

With the share price under pressure and metrics such as value score and analyst targets suggesting a possible gap to current levels, the key question is simple: Is Addus HomeCare undervalued, or is the market already pricing in future growth?

Most Popular Narrative: 15.2% Undervalued

At a last close of $93.26 versus a narrative fair value of $110.03, the current price sits below what this widely followed model suggests, setting up a valuation story built around measured growth and margin assumptions.

The looming threat of significant government healthcare spending cuts to address federal budget deficits could reduce funding for Medicaid and Medicare programs, which are critical revenue streams for Addus HomeCare, this would directly pressure revenue and earnings, especially as provisions of the reconciliation bill begin to impact state budgets in 2028. Persistent and escalating labor costs, including wage increases mandated by state policies and ongoing caregiver shortages, are likely to compress net margins, despite recent hiring success, the long-term demographic shift and intensified competition for caregivers may lead to higher recruitment and retention costs, lowering profitability over time.

Want to see how cautious policy and wage assumptions still support a higher fair value? The narrative leans on measured revenue growth, firmer margins, and a premium earnings multiple that may surprise you.

Result: Fair Value of $110.03 (UNDERVALUED)

However, there are also clear offsets, including steady state level reimbursement support in key markets and recent acquisitions that could keep margins and earnings more resilient than feared.

Next Steps

If the balance of risks and potential rewards feels finely poised, it makes sense to look at the numbers yourself and move quickly to form an independent view. To see what is currently driving optimism, start with the 5 key rewards

Looking for more investment ideas?

If Addus HomeCare has sparked questions about where to look next, do not stop here. Put the market to work for you by testing fresh ideas with focused screeners.

• Target potential mispricings by scanning a curated set of 53 high quality undervalued stocks that combine quality fundamentals with prices that may not fully reflect their profiles.
• Prioritize resilience by reviewing 66 resilient stocks with low risk scores that score well on financial strength and business stability for a calmer ride through market swings.
• Hunt for early-stage opportunities with the screener containing 20 high quality undiscovered gems that have solid fundamentals but limited current attention from the market.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.